Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

110.91

Today's Change

+1.66 (1.51%)

Day's Change

109.39 - 111.56

Trading Volume

43,358

Overview

Market Cap

11 Billion

Shares Outstanding

104 Million

Avg Volume

337,022

Avg Price (50 Days)

102.46

Avg Price (200 Days)

89.23

PE Ratio

165.54

EPS

0.67

Earnings Announcement

15-Feb-2024

Previous Close

109.25

Open

109.54

Day's Range

109.39 - 111.56

Year Range

58.6 - 112.37

Trading Volume

43,673

Price Change Highlight

1 Day Change

1.52%

5 Day Change

2.71%

1 Month Change

5.63%

3 Month Change

10.20%

6 Month Change

41.47%

Ytd Change

15.17%

1 Year Change

83.38%

3 Year Change

137.70%

5 Year Change

460.15%

10 Year Change

13425.61%

Max Change

9544.35%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment